MK-5160

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MK-5160, covering 2019-04-01 to 2019-04-01. Get the full timeline:

Most recent: Clinical Trial Update: Multiple Ascending Dose Study of MK-5160 in Participants With Type 1 and Type 2 Diabetes Mellitus (MK-5160-002) [Phase 1]

See pricing